Workers exposed to a variety of wood dusts are known to experience work-related respiratory symptoms, including occupational asthma. There are, however, few reports of occupational asthma due to spruce wood. We present the case of a 31-year-old sawmill owner with severe asthma caused by exposure to spruce wood dust, who developed asthmatic symptoms after 2 years of working.
Introduction
Workers exposed to a variety of wood dusts are known to be affected by work-related respiratory symptoms, including occupational asthma. Most cases of occupational asthma caused by wood dust have been described as case reports, with the exception of occupational asthma due to western red cedar (WRC; Thuja plicata) [1] . Asthma due to WRC is the most extensively studied, both clinically and immunologically, but asthma associated with exposure to dusts of other woods, including pine, fir, oak, abachi, iroko and bethabara, is also recognized [2] [3] [4] [5] [6] [7] . There are, however, few reports of occupational asthma due to spruce wood [8] . The pathogenic mechanisms of wood dust-induced occupational asthma are generally not established, although some immunoglobulin E (IgE)-mediated sensitization cases have been described [1] . We present a patient with severe asthma caused by exposure to spruce wood dust, in whom a type I immunological mechanism seems to be implicated.
Case report
The subject, a 31-year-old never-smoking owner of a small sawmill, was investigated for suspected occupational asthma by the Centre of Occupational Allergy and Environmental Health. He had worked in the family sawmill for 10 years. During some periods, spruce wood was the main (or only) working material. After 2 years of working, he developed recurrent non-productive cough and dyspnoea with wheezing. These symptoms tended to appear after 30-40 min of exposure to spruce wood dust. When away from work, the symptoms improved. He also reported two episodes of exacerbation of dyspnoea after taking oral aspirin for headache. He was assessed as an outpatient and, because of the severity of his asthma, was treated with the following: oral methylprednisolone (4-32 mg daily), inhaled corticosteroids and β 2 -agonists.
We performed a clinical examination, routine laboratory testing and spirometry, in addition to taking a chest x-ray and evaluating the levels of total serum IgE (ImmunoCap, Phadia, Uppsala, Sweden) and specific serum IgEs for the
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Occupational Medicine 2012;62:301-304 doi:10.1093/occmed/kqs023 following woods: spruce (HYTEC enzyme immunoassay, Hycor Biomedical, USA; and Allergopharma, Reinbeck, Germany), fir, oak, beech and pine; plus formaldehyde, acetylosalicylic acid (aspirin; Allergopharma, Germany), grass and tree pollens, Dermatophagoides sp., moulds di-isocyanates, hexahydrophtalic and methyltetrahydrophtalic anhydrides (ImmunoCap Phadia, Uppsala, Sweden). We also performed skin-prick tests (SPTs) to identify common aeroallergens (dust mites, tree and grass pollens, moulds, feathers and wood of spruce, oak, pine fir and beech) (Allergopharma, Germany). Peak expiratory flow rate (PEFR) was monitored both off work and at work with exposure to spruce wood dust as the patient was reluctant to discontinue supervision in the sawmill despite serious symptoms of dyspnoea. He was asked to take readings three times a day (morning, midday and evening) with a Mini-Wright peak-flow meter (Clement Clarke International, London, UK) for two periods (2 weeks off work after 1 month without exposure and 2 weeks at work during spruce wood dust exposure). We collected the induced sputum for cell evaluation on the second Friday of each period. During PEFR monitoring, the subject continued his standard medication (oral methylprednisolone 16 mg daily and inhaled budesonide (3 × 200 µg daily) and salmeterol (2 × 50 µg daily)). To evaluate the asthmatic symptoms, he completed a daily symptom chart recording daytime cough, dyspnoea, exertion limitations, awakening caused by dyspnoea or cough, and the daily use of rescue medication. The clinical and laboratory findings (including chest X-ray) did not reveal any abnormalities. Total serum IgE was within normal limits (65.15 kU/l). SPT responses to common aeroallergens and woods could not be interpreted because of concomitant oral corticosteroid administration, along with the presence of a negative response to a positive SPT control. Resting spirometry revealed bronchoconstriction, with the forced expiratory volume in 1 s (FEV 1 ) = 2.27 (60% of predicted value), forced vital capacity (FVC) = 3.50 (79% of predicted value) and FEV 1 /FVC = 59.9%. Inhalation of 200 µg of salbutamol produced a 30% increase in the FEV 1 value. The test for identifying specific serum IgE for spruce wood gave positive results (7.80 IU/ml HYTEC, HYCOR, USA; 13.64 kU/l Allergopharma, Germany). Specific serum IgE levels for other wood types were raised, but to a lesser extent (fir wood-0.85 kU/l; oak wood-1.70 kU/l). The other specific serum IgE tests previously mentioned were negative.
During the week off work, the symptoms of dyspnoea remained mild, without significant PEFR variability (mean daily PEFR variability = 13.4 ± 5.3%). However, during the week at work, the daily fluctuations in PEFR were >20% (mean daily PEFR variability = 26.7 ± 12.7%), and the patient needed his rescue medication daily. During the weekend, he improved significantly, with PEFR results similar to those of the off-work period (Figure 1 ).
We observed a raised eosinophil count in the induced sputum after 2 weeks of daily exposure to spruce wood and a significant increase in the symptom score during the at-work period (mean score 3.2 ± 1.5 versus 9.9 ± 2.7; P < 0.001; t-test, SigmaStat 3.5), with an increase in the daily administration of rescue medication (salbutamol 100 µg/dose) ( Table 1) .
Discussion
To our knowledge, the role of IgE in spruce wood-induced asthma has not been described previously. In our patient, a type I allergic reaction is likely to be responsible for the asthmatic reaction. We found specific serum IgE for spruce wood using two independent methods (HYTEC and Allergopharma). We also found IgE specific to fir and oak wood at lower levels, but at the time of workplace PEFR monitoring, the patient was not exposed to these allergens. Laboratory evidence of hyperreactivity to other common and occupational allergens was absent. The results of these tests, analysis of the clinical course of the disease and monitoring of PEFR when off and 
Key points
• This is the first well-documented case of allergic IgE-related occupational asthma induced by spruce wood dust.
• The diagnosis was supported by clinical laboratory tests, accompanied by workplace challenge and the use of a new daily symptom chart.
at work, accompanied by elevated eosinophil counts in induced sputum and a significant increase in symptom score after occupational exposure, justify the diagnosis of occupational asthma. Some species of wood contain anti-inflammatory constituents, which have inhibitory effects on cytokines (tumour necrosis factor-alpha, interleukin-6) or cyclo-oxygenase (COX). These properties have been reported for sesquiterpenol, quercinol, boswellic acid and betulinic acid, and for substances from the woods of Wrightia tinctoria, Sappan lignum and other species [9, 10] . Our patient reported two episodes of exacerbation of dyspnoea after the oral intake of aspirin, which he said he had never previously taken. Specific serum IgE was, however, not present. The potential cross-reactivity between COX inhibitors from different sources should not be overlooked. The possibility of such interactions and the underlying mechanisms require further investigation. 1  -3  3  2  0  4  12  2  -2  2  2  1  2  9  3  -2  2  2  0  2  8  4  -2  3  3  2  4  14  5  -2  2  2  1  5  12  6  -2  1  2  0  2  7  7  -2  1  1  0  1  5  8  -3  2  2  0  3  10  9  -2  2  2  1  2  9  10  -3  2  2  0  3  10  11  -2  3  2  1  4  12  12  7  3  3  3  1  4  14  13  -3  2  2  1  2  10  14  -2  1  2  0  2  7 Mean score 9.9 a 0, absent; 1, mild; 2, moderate; 3, severe. 
